237 related articles for article (PubMed ID: 12594846)
1. Characterization of HLA DR3/DQ2 transgenic mice: a potential humanized animal model for autoimmune disease studies.
Chen D; Ueda R; Harding F; Patil N; Mao Y; Kurahara C; Platenburg G; Huang M
Eur J Immunol; 2003 Jan; 33(1):172-82. PubMed ID: 12594846
[TBL] [Abstract][Full Text] [Related]
2. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells.
de Kauwe AL; Chen Z; Anderson RP; Keech CL; Price JD; Wijburg O; Jackson DC; Ladhams J; Allison J; McCluskey J
J Immunol; 2009 Jun; 182(12):7440-50. PubMed ID: 19494267
[TBL] [Abstract][Full Text] [Related]
3. Humanized transgenic mice expressing HLA DR4-DQ3 haplotype: reconstitution of phenotype and HLA-restricted T-cell responses.
Chen Z; de Kauwe AL; Keech C; Wijburg O; Simpfendorfer K; Alexander WS; McCluskey J
Tissue Antigens; 2006 Sep; 68(3):210-9. PubMed ID: 16948641
[TBL] [Abstract][Full Text] [Related]
4. Role of MHC class II expressing CD4+ T cells in proteolipid protein(91-110)-induced EAE in HLA-DR3 transgenic mice.
Mangalam A; Rodriguez M; David C
Eur J Immunol; 2006 Dec; 36(12):3356-70. PubMed ID: 17125142
[TBL] [Abstract][Full Text] [Related]
5. A 320-kilobase artificial chromosome encoding the human HLA DR3-DQ2 MHC haplotype confers HLA restriction in transgenic mice.
Chen Z; Dudek N; Wijburg O; Strugnell R; Brown L; Deliyannis G; Jackson D; Koentgen F; Gordon T; McCluskey J
J Immunol; 2002 Mar; 168(6):3050-6. PubMed ID: 11884478
[TBL] [Abstract][Full Text] [Related]
6. HLA class II transgenic mice mimic human inflammatory diseases.
Mangalam AK; Rajagopalan G; Taneja V; David CS
Adv Immunol; 2008; 97():65-147. PubMed ID: 18501769
[TBL] [Abstract][Full Text] [Related]
7. Restricted expression of transgenic HLA-DRA gene in thymic epithelial cells and its role in acquisition of T cell tolerance to self-superantigens and processed DR alpha-derived peptide.
Fukui Y; Yamamoto K; Yokoyama N; Iwanaga T; Kurashima C; Esaki Y; Kimura A; Akashi T; Hirokawa K; Sasazuki T
Eur J Immunol; 1993 Jul; 23(7):1678-86. PubMed ID: 8100779
[TBL] [Abstract][Full Text] [Related]
8. A new mouse model of autoimmune ocular myasthenia gravis.
Yang H; Wu B; Tüzün E; Saini SS; Li J; Allman W; Higgs S; Xiao TL; Christadoss P
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5101-11. PubMed ID: 17962462
[TBL] [Abstract][Full Text] [Related]
9. Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4(+) T cells from human DQ transgenic mice.
Wen L; Wong FS; Burkly L; Altieri M; Mamalaki C; Kioussis D; Flavell RA; Sherwin RS
J Clin Invest; 1998 Sep; 102(5):947-57. PubMed ID: 9727063
[TBL] [Abstract][Full Text] [Related]
10. Flexibility of TCR repertoire and permissiveness of HLA-DR3 molecules in experimental autoimmune thyroiditis in nonobese diabetic mice.
Flynn JC; Fuller BE; Giraldo AA; Panos JC; David CS; Kong YC
J Autoimmun; 2001 Aug; 17(1):7-15. PubMed ID: 11488633
[TBL] [Abstract][Full Text] [Related]
11. A multiple transgenic mouse model with a partially humanized activation pathway for helper T cell responses.
Laub R; Dorsch M; Meyer D; Ermann J; Hedrich HJ; Emmrich F
J Immunol Methods; 2000 Dec; 246(1-2):37-50. PubMed ID: 11121545
[TBL] [Abstract][Full Text] [Related]
12. Human thyroglobulin peptide p2340 induces autoimmune thyroiditis in HLA-DR3 transgenic mice.
Karras E; Yang H; Lymberi P; Christadoss P
J Autoimmun; 2005 Jun; 24(4):291-6. PubMed ID: 15927791
[TBL] [Abstract][Full Text] [Related]
13. Co-expression of HLA DR3 and DQ8 results in the development of spontaneous insulitis and loss of tolerance to GAD65 in transgenic mice.
Abraham RS; Kudva YC; Wilson SB; Strominger JL; David CS
Diabetes; 2000 Apr; 49(4):548-54. PubMed ID: 10871191
[TBL] [Abstract][Full Text] [Related]
14. HLA transgenic mice as models of human autoimmune diseases.
Das P; Abraham R; David C
Rev Immunogenet; 2000; 2(1):105-14. PubMed ID: 11324683
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic variance in childhood coeliac disease and the HLA-DQ/DR dose effect.
Vermeulen BA; Hogen Esch CE; Yuksel Z; Koning F; Verduijn W; Doxiadis II; Schreuder GM; Mearin ML
Scand J Gastroenterol; 2009; 44(1):40-5. PubMed ID: 18932050
[TBL] [Abstract][Full Text] [Related]
16. Human leucocyte antigen and TNFalpha polymorphism association in microscopic colitis.
Koskela RM; Karttunen TJ; Niemelä SE; Lehtola JK; Ilonen J; Karttunen RA
Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):276-82. PubMed ID: 18334870
[TBL] [Abstract][Full Text] [Related]
17. Thyrotropin receptor-DNA vaccination of transgenic mice expressing HLA-DR3 or HLA-DQ6b.
Pichurin P; Chen CR; Pichurina O; David C; Rapoport B; McLachlan SM
Thyroid; 2003 Oct; 13(10):911-7. PubMed ID: 14611699
[TBL] [Abstract][Full Text] [Related]
18. Induction of arthritis in HLA-DR4-humanized and HLA-DQ8-humanized mice by human cartilage proteoglycan aggrecan but only in the presence of an appropriate (non-MHC) genetic background.
Szántó S; Bárdos T; Szabó Z; David CS; Buzás EI; Mikecz K; Glant TT
Arthritis Rheum; 2004 Jun; 50(6):1984-95. PubMed ID: 15188376
[TBL] [Abstract][Full Text] [Related]
19. [Gluten enteropathy in Croatian children is primarily associated with the HLA-DR3-DQ2 haplotype].
Jurcić Z; Brkljacić-Surkalović L; Grubić Z; Zunec R; Vezmar V; Kastelan A
Lijec Vjesn; 2000; 122(11-12):259-63. PubMed ID: 11291267
[TBL] [Abstract][Full Text] [Related]
20. Defective costimulatory function is a striking feature of antigen-presenting cells in an HLA-B27-transgenic rat model of spondylarthropathy.
Hacquard-Bouder C; Falgarone G; Bosquet A; Smaoui F; Monnet D; Ittah M; Breban M
Arthritis Rheum; 2004 May; 50(5):1624-35. PubMed ID: 15146433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
